These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

33 related articles for article (PubMed ID: 1874482)

  • 1. Serum transferrin as a marker of bone growth in boys: correlation with serum alkaline phosphatase activity, plasma insulin-like growth factor 1 and rate of growth in height.
    Misaki M; Shima T; Yano Y; Okazaki T
    Horm Metab Res; 1991 May; 23(5):230-2. PubMed ID: 1874482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum insulin/like growth factor I, bone mineral density and biochemical markers of bone metabolism in children with idiopathic osteoporosis.
    Chlebna-Sokol D; Rusinska A
    Endocr Regul; 2001 Dec; 35(4):201-8. PubMed ID: 11858767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum levels of insulin-like growth factor binding proteins (IGFBP)-4 and -5 correlate with bone mineral density in growth hormone (GH)-deficient adults and increase with GH replacement therapy.
    Thorén M; Hilding A; Brismar T; Magnusson P; Degerblad M; Larsson L; Sääf M; Baylink DJ; Mohan S
    J Bone Miner Res; 1998 May; 13(5):891-9. PubMed ID: 9610754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of iodine deficiency on insulin-like growth factor-I, insulin-like growth factor-binding protein-3 levels and height attainment in malnourished children.
    Wan Nazaimoon WM; Osman A; Wu LL; Khalid BA
    Clin Endocrinol (Oxf); 1996 Jul; 45(1):79-83. PubMed ID: 8796142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different responses of bone alkaline phosphatase isoforms during recombinant insulin-like growth factor-I (IGF-I) and during growth hormone therapy in adults with growth hormone deficiency.
    Magnusson P; Degerblad M; Sääf M; Larsson L; Thorén M
    J Bone Miner Res; 1997 Feb; 12(2):210-20. PubMed ID: 9041052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of growth hormone on insulin-like growth factor I and bone metabolism in distraction osteogenesis.
    Bail HJ; Kolbeck S; Lindner T; Dahne M; Weiler A; Windhagen HJ; Raun K; Skjaerbaek C; Flyvbjerg A; Ørskov H; Haas NP; Raschke MJ
    Growth Horm IGF Res; 2001 Oct; 11(5):314-23. PubMed ID: 11735250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma transferrin levels in abnormal endocrine states. II. The changes in various endocrine states.
    Matsubara M; Koyanagawa Y; Odagaki E; Nakagawa K
    Horm Metab Res; 1989 Jun; 21(6):334-7. PubMed ID: 2777192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of serum insulin-like growth factor-I and erythropoiesis in relation to body iron status.
    Choi JW; Kim SK
    Ann Clin Lab Sci; 2004; 34(3):324-8. PubMed ID: 15487708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Serum osteocalcin in children with chronic renal insufficiency].
    Peco-Antić A; Nastić-Mirić D; Milikić V; Babić D; Pejcić I; Kostić M; Paripović V; Jovanović O; Kruscić D; Mancić J
    Srp Arh Celok Lek; 1996; 124(9-10):227-31. PubMed ID: 9102853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationships between pubertal development, IGF-1 axis, and bone formation in healthy adolescents.
    Kanbur NO; Derman O; Kinik E
    J Bone Miner Metab; 2005; 23(1):76-83. PubMed ID: 15616898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linear growth in relation to the circulating concentrations of insulin-like growth factor I, parathyroid hormone, and 25-hydroxy vitamin D in children with nutritional rickets before and after treatment: endocrine adaptation to vitamin D deficiency.
    Soliman AT; Al Khalaf F; Alhemaidi N; Al Ali M; Al Zyoud M; Yakoot K
    Metabolism; 2008 Jan; 57(1):95-102. PubMed ID: 18078865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Procollagen type I carboxy-terminal extension peptide in serum as a marker of collagen biosynthesis in bone. Correlation with Iliac bone formation rates and comparison with total alkaline phosphatase.
    Parfitt AM; Simon LS; Villanueva AR; Krane SM
    J Bone Miner Res; 1987 Oct; 2(5):427-36. PubMed ID: 3455625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of economic status on height, insulin-like growth factor (IGF)-I and IGF binding protein-3 concentrations in healthy Turkish children.
    Turan S; Bereket A; Furman A; Omar A; Berber M; Ozen A; Akbenlioglu C; Haklar G
    Eur J Clin Nutr; 2007 Jun; 61(6):752-8. PubMed ID: 17164829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A possible relationship between cord blood transferrin and birth length in infants.
    Misaki M; Kumazawa M; Sugita M; Shima T; Okazaki T
    Horm Res; 1987; 25(4):228-31. PubMed ID: 3583232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pubertal growth as reflected by simultaneous changes in bone mineral content and serum alkaline phosphatase.
    Krabbe S; Christiansen C; Rødbro P; Transbøl I
    Acta Paediatr Scand; 1980 Jan; 69(1):49-52. PubMed ID: 7368911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced leucocyte alkaline phosphatase activity and decreased NBT reduction test in induced iron deficiency anaemia in rabbits.
    Celada A; Herreros V; Pugin P; Rudolf H
    Br J Haematol; 1979 Nov; 43(3):457-63. PubMed ID: 387063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemoglobin, serum iron and iron binding capacity during growth from age 9 to 17. Semi-longitudinal study of boys and girls.
    De Wijn JF; Pikaar NA
    Nutr Metab; 1971; 13(1):44-53. PubMed ID: 5099395
    [No Abstract]   [Full Text] [Related]  

  • 18. [The clinical significance of the measurement of plasma transferrin as a growth factor. II. The changes in various endocrine status].
    Matsubara M; Odagaki E; Morioka T; Nakagawa K
    Nihon Naibunpi Gakkai Zasshi; 1987 May; 63(5):669-74. PubMed ID: 3622861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma transferrin concentration as a nutritional marker in malnourished dogs with nutritional treatment.
    Nakajima M; Ohno K; Goto-Koshino Y; Fujino Y; Tsujimoto H
    J Vet Med Sci; 2014 Apr; 76(4):539-43. PubMed ID: 24366156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on familial hypotransferrinemia: unique clinical course and molecular pathology.
    Hayashi A; Wada Y; Suzuki T; Shimizu A
    Am J Hum Genet; 1993 Jul; 53(1):201-13. PubMed ID: 8317485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.